Hana Bavlovič Piskáčková (Hana Bavlovič-Piskáčková)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 3

Top Topics

Locally Advanced

Squamous Cell Carcinoma

Top Venues

Circulation. Heart failure

The Journal of pharmacology and experimental therapeutics

Toxicological sciences : an official journal of the Society of Toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Veronika Skalická, Jan Kubeš, Lenka Applová, Petra Kollárová-Brázdová, Olga Lenčová-Popelová, Iuliia Melnikova, Galina Karabanovich, Mushtaq Mufleh Khazeem, Hana Bavlovič Piskáčková, Petra Štěrbová-Kovaříková, Caroline A Austin, Jaroslav Roh, Martin Sterba, Tomáš Šimůnek, Anna Jirkovská
Exploring the effects of topoisomerase II inhibitor XK469 on anthracycline cardiotoxicity and DNA damage. Toxicological sciences : an official journal of the Society of Toxicology (2024)
Eduard Jirkovsky, Anna Jirkovská, Hana Bavlovič Piskáčková, Veronika Skalická, Zuzana Pokorná, Galina Karabanovich, Petra Kollárová-Brázdová, Jan Kubeš, Olga Lenčová-Popelová, Yvona Mazurová, Michaela Adamcová, Alexander R Lyon, Jaroslav Roh, Tomáš Šimůnek, Martin Sterba
Clinically Translatable Prevention of Anthracycline Cardiotoxicity by Dexrazoxane Is Mediated by Topoisomerase II Beta and Not Metal Chelation. Circulation. Heart failure 14 (11) (2021)
Petra Kollárová-Brázdová, Anna Jirkovská, Galina Karabanovich, Zuzana Pokorná, Hana Bavlovič Piskáčková, Eduard Jirkovsky, Jan Kubeš, Olga Lenčová-Popelová, Yvona Mazurová, Michaela Adamcová, Veronika Skalická, Petra Štěrbová-Kovaříková, Jaroslav Roh, Tomáš Šimůnek, Martin Sterba
Investigation of Structure-Activity Relationships of Dexrazoxane Analogs Reveals Topoisomerase IIβ Interaction as a Prerequisite for Effective Protection against Anthracycline Cardiotoxicity. The Journal of pharmacology and experimental therapeutics 373 (3) (2020)